Autoimmune hepatitis and overlap syndromes (Q34746158)

4 August 2017

1 reference

title

Autoimmune hepatitis and overlap syndromes. (English)

1 reference

4 August 2017

1 reference

1

Hans Peter Dienes

1 reference

4 August 2017

Heike Erberich

2

1 reference

4 August 2017

Volker Dries

series ordinal

3

1 reference

4 August 2017

Peter Schirmacher

series ordinal

4

1 reference

4 August 2017

Ansgar Lohse

series ordinal

5

1 reference

4 August 2017

1 May 2002

1 reference

4 August 2017

Clinics in liver disease

1 reference

4 August 2017

6

1 reference

4 August 2017

2

1 reference

4 August 2017

349-62, vi

1 reference

Autoimmunity and liver disease

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Frequency and nature of the variant syndromes of autoimmune liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Autoimmune overlap syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

The molecular structure of autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Natural history of early primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

[Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)]

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Cytoplasmic autoantigens in autoimmune hepatitis: molecular analysis and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease -- possible association with a steroid-resistant transplant rejection episode.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Serum soluble HLA-DR antigens in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Ultrastructural lesion in autoimmune hepatitis and steps of the immune response in liver tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Recent developments in autoimmune liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Ludwig Symposium on biliary disorders--part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Antimitochondrial antibodies in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Diagnosis of primary sclerosing cholangitis--autoimmune hepatitis overlap syndrome: to score or not to score?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Autoimmune cholangitis within the spectrum of autoimmune liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Current concepts in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Diagnosis and treatment of primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

Primary sclerosing cholangitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900007-7

7 January 2021

10.1016/S1089-3261(02)00007-7

Identifiers

DOI

1 reference

4 August 2017

1 reference